Database of adverse events associated with drugs and drug combinations
Open Access
- 27 December 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Abstract
Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA’s postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature.Keywords
Funding Information
- University of Northern Iowa Professional Development award
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM122845)
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG057555)
This publication has 39 references indexed in Scilit:
- Data-Driven Prediction of Drug Effects and InteractionsScience Translational Medicine, 2012
- A Likelihood Ratio Test Based Method for Signal Detection With Application to FDA’s Drug Safety DataJournal of the American Statistical Association, 2011
- Normalized names for clinical drugs: RxNorm at 6 yearsJournal of the American Medical Informatics Association, 2011
- Compressive sampling2007
- Statins' dosage in patients with renal failure and cyclosporine drug–drug interactions in transplant recipient patientsInternational Journal of Cardiology, 2005
- Propensity score methods in drug safety studies: practice, strengths and limitationsPharmacoepidemiology and Drug Safety, 2001
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999
- A spatial scan statisticCommunications in Statistics - Theory and Methods, 1997
- SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1Transplantation, 1996
- EFFECTS OF CYCLOSPORIN ON PREDNISOLONE METABOLISMThe Lancet, 1984